|
|
|
|
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
|
|
|
|
|
|
|
|
نویسنده
|
kesselheim a.s. ,treasure c.l. ,joffe s.
|
|
منبع
|
plos medicine - 2017 - دوره : 14 - شماره : 1
|
|
چکیده
|
[no abstract available]
|
|
|
|
|
آدرس
|
program on regulation,therapeutics,and law (portal),division of pharmacoepidemiology and pharmacoeconomics,department of medicine,brigham and women’s hospital and harvard medical school,boston,ma, United States, program on regulation,therapeutics,and law (portal),division of pharmacoepidemiology and pharmacoeconomics,department of medicine,brigham and women’s hospital and harvard medical school,boston,ma, United States, department of medical ethics & health policy,university of pennsylvania perelman school of medicine,philadelphia,pa,united states,leonard davis institute of health economics,university of pennsylvania,philadelphia,pa, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|